Neuroendocrine cancer trials. Neuroendocrine cancer network - Sevastita Iordache - Google Scholar Citations

Neuroendocrine cancer trials

neuroendocrine cancer trials condyloma bushke

This phase trial evaluated the safety cervical cancer young females efficacy of the hafnium oxide HfO2 nanoparticle NBTXR3 activated by radiotherapy versus radiotherapy alone as a pre-operative cervical cancer young females in patients with locally advanced soft-tissue sarcoma.

Sarc is a phase randomised, multicentre, international trial.

neuroendocrine cancer trials excizia verucilor genitale

Patients had to have a WHO performance status of and a life expectancy of at least 6 months. Randomisation was stratified by histological subtype myxoid liposarcoma vs others.

neuroendocrine cancer trials medicament bun pentru a preveni paraziții

This was an open-label study. The primary endpoint was the proportion of patients with a pathological complete response, assessed by a oxiuri la nou nascuti каким способом заработать много денег review board following European Organisation for Research and Treatment of Cancer guidelines in the intention-to-treat population full cervical cancer young females set.

Institute of Oncology Prof. Dr. Alexandru Trestioreanu, Romania

Safety analyses were done in all patients who received at least one puncture and injection of NBTXR3 or at least one dose of radiotherapy. This study is registered with ClinicalTrials.

neuroendocrine cancer trials preparate plantare de îndepărtare a negilor

Two patients in the NBTXR3 group and one patient in the radiotherapy neuroendocrine cancer trials were excluded from the efficacy analysis because they were subsequently discovered to be ineligible; thus, a total of patients were analysed for the neuroendocrine cancer trials endpoint in the intention-to-treat full analysis set 87 in the NBTXR3 group and 89 in the radiotherapy alone group. No treatment-related deaths occurred.

neuroendocrine cancer trials îndepărtarea condilomului belgorod

Mai multe despre acest subiect